Juliet Emamaullee, MD, PhD, FRCSC, FACS News

A new class of drugs can relieve itching for cholestatic childhood liver disease and potentially lengthen time until a liver transplant is necessary.

CHLA-led study shows reducing disparities in assigning livers for transplant improved outcomes for patients with pediatric acute liver failure.

Receiving a liver transplant means also living with the possibility of rejection. Transplant rejection occurs when the body’s immune system attacks the new organ. This risk is highest in the first

CHLA researchers use imaging mass cytometry analysis of biopsies to find potential biomarkers that can predict transplant rejection.

Children’s Hospital Los Angeles research study uncovers socioeconomic factors that can impact outcomes of patients with pediatric acute liver failure (PALF).

Children’s Hospital Los Angeles researchers develop app to predict if children with acute liver failure will need an urgent liver transplant or can recover on their own.

Study finds that T-cells expressing PD-1 may help predict recovery in children with acute liver failure.

A surgeon and Research Director for the Division of Abdominal Organ Transplantation, Dr. Emamaullee is taking a high-tech approach to challenge that status quo.